159 related articles for article (PubMed ID: 15285727)
1. Soluble urokinase plasminogen activator receptor in blood transfusion components.
Riisbro R; Brünner N; Christensen IJ; Nielsen HJ
Transfus Med; 2004 Aug; 14(4):305-12. PubMed ID: 15285727
[TBL] [Abstract][Full Text] [Related]
2. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
3. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
Ostrowski SR; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
Scand J Immunol; 2005 Apr; 61(4):347-56. PubMed ID: 15853918
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
Begum FD; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Bock JE; Glud E; Høyer-Hansen G; Ring-Larsen H; Høgdall EV
Anticancer Res; 2004; 24(3b):1981-5. PubMed ID: 15274388
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
Riisbro R; Christensen IJ; Piironen T; Greenall M; Larsen B; Stephens RW; Han C; Høyer-Hansen G; Smith K; Brünner N; Harris AL
Clin Cancer Res; 2002 May; 8(5):1132-41. PubMed ID: 12006529
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.
Ostrowski SR; Ullum H; Goka BQ; Høyer-Hansen G; Obeng-Adjei G; Pedersen BK; Akanmori BD; Kurtzhals JA
J Infect Dis; 2005 Apr; 191(8):1331-41. PubMed ID: 15776381
[TBL] [Abstract][Full Text] [Related]
8. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection.
Perch M; Kofoed P; Fischer TK; Có F; Rombo L; Aaby P; Eugen-Olsen J
Parasite Immunol; 2004 May; 26(5):207-11. PubMed ID: 15491469
[TBL] [Abstract][Full Text] [Related]
10. Soluble vascular endothelial growth factor in various blood transfusion components.
Nielsen HJ; Werther K; Mynster T; Brünner N
Transfusion; 1999 Oct; 39(10):1078-83. PubMed ID: 10532601
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract][Full Text] [Related]
12. Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro.
Nielsen HJ; Werther K; Mynster T; Svendsen MN; Rosendahl S; Elley T; Skov F
Vox Sang; 2001 Apr; 80(3):170-8. PubMed ID: 11449957
[TBL] [Abstract][Full Text] [Related]
13. Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation.
Mynster T; Dybkjaer E; Reimert CM; Pedersen AN; Ostergaard K; Vangsgaard K; Nielsen HJ
Inflamm Res; 1999 Jul; 48(7):363-8. PubMed ID: 10450785
[TBL] [Abstract][Full Text] [Related]
14. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
[TBL] [Abstract][Full Text] [Related]
15. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.
Eugen-Olsen J; Gustafson P; Sidenius N; Fischer TK; Parner J; Aaby P; Gomes VF; Lisse I
Int J Tuberc Lung Dis; 2002 Aug; 6(8):686-92. PubMed ID: 12150480
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC).
Begum FD; Høgdall EV; Riisbro R; Christensen IJ; Engelholm SA; Jørgensen M; Pedersen BN; Høgdall CK
APMIS; 2006 Oct; 114(10):675-81. PubMed ID: 17004970
[TBL] [Abstract][Full Text] [Related]
18. Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components.
Holten-Andersen MN; Brunner N; Christensen IJ; Jensen V; Nielsen HJ
Scand J Clin Lab Invest; 2002; 62(3):223-30. PubMed ID: 12088341
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma urokinase receptor predicts low birth weight in maternal malaria.
Ostrowski SR; Shulman CE; Peshu N; Staalsøe T; Høyer-Hansen G; Pedersen BK; Marsh K; Ullum H
Parasite Immunol; 2007 Jan; 29(1):37-46. PubMed ID: 17187653
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
Ostrowski SR; Katzenstein TL; Pedersen M; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
Scand J Immunol; 2006 Jun; 63(6):478-86. PubMed ID: 16764702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]